Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2002 Feb;11(1):47–51. doi: 10.1080/09629350210307

Evidence for local inflammation in complex regional pain syndrome type 1.

Frank J P M Huygen 1, Anke G J De Bruijn 1, Martha T De Bruin 1, J George Groeneweg 1, Jan Klein 1, Freek J Zijistra 1
PMCID: PMC1781643  PMID: 11930962

Abstract

BACKGROUND: The pathophysiology of complex regional pain syndrome type 1 (CRPS 1) is still a matter of debate. Peripheral afferent, efferent and central mechanisms are supposed. Based on clinical signs and symptoms (e.g. oedema, local temperature changes and chronic pain) local inflammation is suspected. AIM: To determine the involvement of neuropetides, cytokines and eicosanoids as locally formed mediators of inflammation. METHODS: In this study, nine patients with proven CRPS 1 were included. Disease activity and impairment was determined by means of a Visual Analogue Scale, the McGill Pain Questionnaire, the difference in volume and temperature between involved and uninvolved extremities, and the reduction in active range of motion of the involved extremity. Venous blood was sampled from and suction blisters made on the involved and uninvolved extremities for measurement of cytokines interleukin (IL)-6, II-1beta and tumour necrosis factor-alpha (TNF-alpha), the neuropetides NPY and CRGP, and prostaglandin E2RESULTS: The patients included in this study did have a moderate to serious disease activity and impairment. In plasma, no changes of mediators of inflammation were observed. In blister fluid, however, significantly higher levels of IL-6 and TNF-alpha in the involved extremity were observed in comparison with the uninvolved extremity. CONCLUSIONS: This is the first time that involvement of mediators of inflammation in CRPS 1 has been so clearly and directly demonstrated. This observation opens new approaches for the succesful use and development of immunosuppressives in CRPS 1.

Full Text

The Full Text of this article is available as a PDF (149.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulla F. A., Smith P. A. Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons. Neuroscience. 1999 Mar;89(1):43–60. doi: 10.1016/s0306-4522(98)00443-6. [DOI] [PubMed] [Google Scholar]
  2. Ameglio F., Bonifati C., Pietravalle M., Fazio M. Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology. 1994;189(4):359–363. doi: 10.1159/000246879. [DOI] [PubMed] [Google Scholar]
  3. Blair S. J., Chinthagada M., Hoppenstehdt D., Kijowski R., Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg. 1998 Dec;64(4):448–451. [PubMed] [Google Scholar]
  4. Bonifati C., Ameglio F., Carducci M., Sacerdoti G., Pietravalle M., Fazio M. Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients. Acta Derm Venereol Suppl (Stockh) 1994;186:23–24. [PubMed] [Google Scholar]
  5. Bonifati C., Carducci M., Cordiali Fei P., Trento E., Sacerdoti G., Fazio M., Ameglio F. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients--relationships with disease severity. Clin Exp Dermatol. 1994 Sep;19(5):383–387. doi: 10.1111/j.1365-2230.1994.tb02687.x. [DOI] [PubMed] [Google Scholar]
  6. Branchet-Gumila M. C., Boisnic S., Le Charpentier Y., Nonotte I., Montastier C., Breton L. Neurogenic modifications induced by substance P in an organ culture of human skin. Skin Pharmacol Appl Skin Physiol. 1999 Jul-Aug;12(4):211–220. doi: 10.1159/000066245. [DOI] [PubMed] [Google Scholar]
  7. Bruehl S., Harden R. N., Galer B. S., Saltz S., Bertram M., Backonja M., Gayles R., Rudin N., Bhugra M. K., Stanton-Hicks M. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 1999 May;81(1-2):147–154. doi: 10.1016/s0304-3959(99)00011-1. [DOI] [PubMed] [Google Scholar]
  8. Calder J. S., Holten I., McAllister R. M. Evidence for immune system involvement in reflex sympathetic dystrophy. J Hand Surg Br. 1998 Apr;23(2):147–150. doi: 10.1016/s0266-7681(98)80162-9. [DOI] [PubMed] [Google Scholar]
  9. Carlsson A. M. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983 May;16(1):87–101. doi: 10.1016/0304-3959(83)90088-X. [DOI] [PubMed] [Google Scholar]
  10. Cheshire W. P., Snyder C. R. Treatment of reflex sympathetic dystrophy with topical capsaicin. Case report. Pain. 1990 Sep;42(3):307–311. doi: 10.1016/0304-3959(90)91143-7. [DOI] [PubMed] [Google Scholar]
  11. Drummond P. D., Finch P. M., Edvinsson L., Goadsby P. J. Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain. Clin Auton Res. 1994 Jun;4(3):113–116. doi: 10.1007/BF01845774. [DOI] [PubMed] [Google Scholar]
  12. Drummond P. D., Skipworth S., Finch P. M. alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Lond) 1996 Jul;91(1):73–77. doi: 10.1042/cs0910073. [DOI] [PubMed] [Google Scholar]
  13. ECCLES M. V. Hand volumetrics. Br J Phys Med. 1956 Jan;19(1):5–8. [PubMed] [Google Scholar]
  14. Heerschap A., den Hollander J. A., Reynen H., Goris R. J. Metabolic changes in reflex sympathetic dystrophy: a 31P NMR spectroscopy study. Muscle Nerve. 1993 Apr;16(4):367–373. doi: 10.1002/mus.880160405. [DOI] [PubMed] [Google Scholar]
  15. Hershler C., Conine T. A., Nunn A., Hannay M. Assessment of an infra-red non-contact sensor for routine skin temperature monitoring: a preliminary study. J Med Eng Technol. 1992 May-Jun;16(3):117–122. doi: 10.3109/03091909209021973. [DOI] [PubMed] [Google Scholar]
  16. Huygen F. J., de Bruijn A. G., Klein J., Zijlstra F. J. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol. 2001 Oct 19;429(1-3):101–113. doi: 10.1016/s0014-2999(01)01310-3. [DOI] [PubMed] [Google Scholar]
  17. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975 Sep;1(3):277–299. doi: 10.1016/0304-3959(75)90044-5. [DOI] [PubMed] [Google Scholar]
  18. Oerlemans H. M., Oostendorp R. A., de Boo T., van der Laan L., Severens J. L., Goris J. A. Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I. Arch Phys Med Rehabil. 2000 Jan;81(1):49–56. [PubMed] [Google Scholar]
  19. Oyen W. J., Arntz I. E., Claessens R. M., Van der Meer J. W., Corstens F. H., Goris R. J. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain. 1993 Nov;55(2):151–157. doi: 10.1016/0304-3959(93)90144-E. [DOI] [PubMed] [Google Scholar]
  20. Prens E. P., Benne K., van Damme J., Bakkus M., Brakel K., Benner R., van Joost T. Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol. 1990 Dec;95(6 Suppl):121S–124S. doi: 10.1111/1523-1747.ep12874991. [DOI] [PubMed] [Google Scholar]
  21. Reilly D. M., Green M. R. Eicosanoid and cytokine levels in acute skin irritation in response to tape stripping and capsaicin. Acta Derm Venereol. 1999 May;79(3):187–190. doi: 10.1080/000155599750010931. [DOI] [PubMed] [Google Scholar]
  22. Rumsfield J. A., West D. P. Topical capsaicin in dermatologic and peripheral pain disorders. DICP. 1991 Apr;25(4):381–387. doi: 10.1177/106002809102500409. [DOI] [PubMed] [Google Scholar]
  23. Stanton-Hicks M., Jänig W., Hassenbusch S., Haddox J. D., Boas R., Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995 Oct;63(1):127–133. doi: 10.1016/0304-3959(95)00110-E. [DOI] [PubMed] [Google Scholar]
  24. Veldman P. H., Reynen H. M., Arntz I. E., Goris R. J. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993 Oct 23;342(8878):1012–1016. doi: 10.1016/0140-6736(93)92877-v. [DOI] [PubMed] [Google Scholar]
  25. Weber M., Birklein F., Neundörfer B., Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain. 2001 Apr;91(3):251–257. doi: 10.1016/S0304-3959(00)00445-0. [DOI] [PubMed] [Google Scholar]
  26. van de Beek W. J., Remarque E. J., Westendorp R. G., van Hilten J. J. Innate cytokine profile in patients with complex regional pain syndrome is normal. Pain. 2001 Apr;91(3):259–261. doi: 10.1016/S0304-3959(00)00443-7. [DOI] [PubMed] [Google Scholar]
  27. van der Kloot W. A., Oostendorp R. A., van der Meij J., van den Heuvel J. De Nederlandse versie van 'McGill pain questionnaire': een betrouwbare pijnvragenlijst. Ned Tijdschr Geneeskd. 1995 Apr 1;139(13):669–673. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES